Article
Targeting autoreactive B cells in rheumatoid arthritis through MHC class I-presented BCR-derived neo-epitopes.
Journal of autoimmunity - 1 Aug 2026
van de Wetering Renee, Kampstra Arieke S B, Kester Michel G D, Tjokrodirijo Rayman T N, de Ru Arnoud H, van Veelen P A, Fehres Cynthia M, Heemskerk Mirjam H M, Toes René E M
Abstract excerpt
Somatic mutations can generate neoantigens recognized by CD8+ T cells, enabling targeted elimination of mutated cells. Currently established B cell-targeting therapies in human B cell-mediated autoimmune diseases lack specificity and fail to achieve durable remission. Since autoreactive B cells often express B cell receptors (BCRs) that have undergone extensive somatic hypermutations (SHM), we hypothesized that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
